| 浅谈中国药典起草与基础研究工作 |
| |
| 引用本文： | 张文婷,王嘉仡,马新.浅谈中国药典起草与基础研究工作[J].世界科学技术,2002,4(4):17-19. |
| |
| 作者姓名： | 张文婷 王嘉仡 马新 |
| |
| 作者单位： | [1]浙江省药品检验所，杭州310004 [2]辽宁省药品监督管理局，沈阳110006 |
| |
| 摘 要： | 本文从TLC鉴别对照药材的确定、含量测定指标的选择及限度制订等方面，指出了中国药典起草与实际应用的相关性，并就毒性药材中毒性成分的量效关系的研究、成分与药效的研究、加快指纹谱基础研究的进度等基础研究工作方面，以及如何更深入地完善中药质量标准提出了设想。
|
| 关 键 词： | 中国药典 基础研究 药材 含量限度 指纹谱 中药质量标准 |
| 修稿时间： | 2002年2月21日 |
A Brief Discussion on Drafting and Basic Research of Chinese Pharmacopoeia |
| |
| Zhang Wenting.A Brief Discussion on Drafting and Basic Research of Chinese Pharmacopoeia[J].World Science and Technology(Modernization of Traditional Chinese Medicine),2002,4(4):17-19. |
| |
| Authors: | Zhang Wenting |
| |
| Abstract: | This article points out the relatianship between the drafting and the application of Chinese pharmacopoeia on the basis of the comparison of TLC identification criteria of drugs with the definition of medicinal materials as well as the selection and the formulation of the limits of identification criteria of medicinal material contents.It makes also suggestions on how to strengthen such basic researches as the relationship between quantity and effectiveness of toxic contents in toxic medicinal materials,the constituents and their effectiveness and the acceleration of the fingerprint of Chinese materia medica so as to further improve the standard of the quality of Chinese drugs. |
| |
| Keywords: | pharmacopoeia medicinal material content limit fingerprint |
| 本文献已被 CNKI 维普 等数据库收录！ |
